Dr. Anil Bhogaraju

Hematology/oncology

Texas, United States

About Dr. Bhogaraju

Dr. Bhogaraju is an Hematology/oncology Specialist in Flower Mound, Texas. He graduated from medical school in 1991. Dr. Bhogaraju accepts Medicare approved amount as full payment. 
The medical group (Texas Onco) Dr. Bhogaraju works with accepts Medicare approved amount as full payment.


Full Name
Anil Bhogaraju

Specialty
Hematology/oncology
Internal Medicine, Medical Oncology

School
Other

Graduated class of
1991


NPI
1578508222

PAC ID
2147483647

Clinician Enrollment ID
I20100218000332
Cities

1

Number of cities where Dr. Bhogaraju has offices
Offices

1

Number of offices
Hospitals

3

Number of hospitals

Office Locations

FLOWER MOUND Office

Phone: (972) 537-4100

4370 Medical Arts Dr
Suite 100
Flower Mound, TX - 75028-1713


Hospitals

TEXAS HEALTH PRESBYTERIAN HOSPITAL FLOWER MOUND

CMS Certification Number: 670068

MEDICAL CITY LEWISVILLE

CMS Certification Number: 450669

BAYLOR SCOTT AND WHITE MEDICAL CENTER CARROLLTON

CMS Certification Number: 450730

Doctors and Clinicians Utilization Data

SpecialtyHCPCS codeCode descriptionService Count Beneficiary count
Hematology/oncology 71250 CT scan chest 21 21
Hematology/oncology 74176 CT scan of abdomen and pelvis 12 12
Hematology/oncology 78815 Nuclear medicine study with CT imaging skull base to mid-thigh 41 34
Hematology/oncology 85027 Complete blood cell count (red cells, white blood cell, platelets), automated test 71 29
Hematology/oncology 96366 Infusion into a vein for therapy, prevention, or diagnosis 81 13
Hematology/oncology 96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention 219 78
Hematology/oncology 96375 Injection of different drug or substance into a vein for therapy, diagnosis, or prevention 552 85
Hematology/oncology 96413 Infusion of chemotherapy into a vein up to 1 hour 434 94
Hematology/oncology G9678 Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation 419 64
Hematology/oncology J0897 Injection, denosumab, 1 mg 4680 21

Questions & Answers


Help others like you find out more about . Do you know the answers to any of these questions? Contribute now and help others like you.